WATERS CORP /DE/ WAT

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $412.18
Market Cap $40.61B
P/E Ratio 38.31
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑7.0% YoY
$3.17B
3-Yr CAGR: 2.1%
Net Income ↑0.8% YoY
$642.63M
Net Margin: 20.3%
Free Cash Flow ↓-12.9% YoY
$539.81M
FCF Yield: 1.33%
EPS (Diluted) ↑0.5% YoY
$10.76
Basic: $10.80
Return on Equity Efficiency
25.1%
ROA: 29.9%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (WAT)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $2,167.4M $1,276.0M $521.5M $6.41 $629.1M
FY 2017 $2,309.1M +6.5% $1,362.0M $20.3M -96.1% $0.25 -96.1% $697.6M
FY 2018 $2,419.9M +4.8% $1,427.4M $593.8M +2,823.5% $7.65 +2,960.0% $604.4M
FY 2019 $2,406.6M -0.6% $1,395.9M $592.2M -0.3% $8.69 +13.6% $643.1M
FY 2020 $2,365.4M -1.7% $1,358.7M $521.6M -11.9% $8.36 -3.8% $790.5M
FY 2021 $2,785.9M +17.8% $1,629.3M $692.8M +32.8% $11.17 +33.6% $747.3M
FY 2022 $2,972.0M +6.7% $1,723.8M $707.8M +2.2% $11.73 +5.0% $611.7M $435.7M
FY 2023 $2,956.4M -0.5% $1,761.2M $642.2M -9.3% $10.84 -7.6% $602.8M $442.2M +1.5%
FY 2024 $2,958.4M +0.1% $1,758.2M $637.8M -0.7% $10.71 -1.2% $762.1M $619.6M +40.1%
FY 2025 $3,165.3M +7.0% $1,876.5M $642.6M +0.8% $10.76 +0.5% $652.6M $539.8M -12.9%
$

Valuation

Market Price $412.18
Market Cap $40.61B
Enterprise Value $40.97B
P/E Ratio 38.31
P/B Ratio 15.80
FCF Yield 1.33%
Dividend Yield N/A
Shares Outstanding 98,185,900
%

Profitability & Margins

Gross Margin 59.28%
Operating Margin 25.36%
Net Margin 20.30%
Return on Equity (ROE) 25.09%
Return on Assets (ROA) 29.92%
Asset Turnover 1.47x
Revenue 3-Yr CAGR 2.12%
🛡️

Financial Health & Liquidity

Current Ratio 1.73
Cash Ratio 0.47
Debt / Equity 0.370
Debt / Assets 0.441
Cash & Equivalents $587.83M
Total Debt $947.45M
Book Value / Share $26.09
💧

Cash Flow Efficiency

Operating Cash Flow $652.55M
Capital Expenditures (CapEx) $112.75M
Free Cash Flow $539.81M
OCF / Revenue 20.62%
FCF / Revenue 17.05%
FCF 3-Yr CAGR 7.40%
🏷️

Per Share Metrics

EPS (Diluted) $10.76
EPS (Basic) $10.80
Dividends / Share N/A
Book Value / Share $26.09
EPS YoY Growth 0.47%
🏛️

Balance Sheet (FY 2025)

Total Assets $2.15B
Total Liabilities $1.24B
Stockholders' Equity $2.56B
Current Assets $2.15B
Current Liabilities $1.24B